Skip to Content

Primavax

Active Substance: diphtheria toxoid purified / hepatitis B, recombinant surface antigen / tetanus toxoid purified
Common Name: diphtheria, tetanus and hepatitis B vaccine, adsorbed
ATC Code: J07CA
Marketing Authorisation Holder: Pasteur Mèrieux MSD
Active Substance: diphtheria toxoid purified / hepatitis B, recombinant surface antigen / tetanus toxoid purified
Status: Withdrawn
Authorisation Date: 1998-02-05
Therapeutic Area: Hepatitis B Diphtheria Immunization Tetanus
Pharmacotherapeutic Group: Vaccines

Therapeutic Indication

This vaccine is indicated for active immunization against hepatitis B, caused by all known subtypes, diphtheria and tetanus in infants :
- for primary vaccination
- for booster
according to national vaccination policies.
This vaccine should not be administered to neonates.
This vaccine is not intended for use in adolescents or adults.

The marketing authorisation for Primavax has been withdrawn at the request of the marketing authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide